)
)
Gabather Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Gabather
Access all reports
Gabather AB is a pharmaceutical company dedicated to developing therapeutics for central nervous system diseases. The company focuses on creating novel drug candidates primarily for the treatment of neuropsychiatric disorders, including anti-psychotics, anti-depressants, anxiolytics, analgesics, and cognition-enhancing treatments. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Prada: The Story of an Icon
Prada's journey from a small Milan boutique to a global luxury empire, led by Miuccia's innovation and creativity.
5 Dec 2024
)
Hims & Hers: Bridging Gaps in Telehealth
Hims & Hers was founded in 2016 by Andrew Dudum and has grown into a ~$4 billion company in the telehealth industry in less than a decade.
5 Dec 2024
)
Andrew Dudum: Founder and CEO of Hims & Hers
Andrew Dudum is the founder and CEO of Hims & Hers, an innovative telehealth company focused on bridging the gap between consumers and healthcare.
4 Dec 2024
Ticker symbol
GABA
Country
🇸🇪 Sweden